Gain insights from ServiceTitan's Q1 2026 earnings call, highlighting 29% subscription revenue growth, AI-driven innovations, and raised guidance for ...

Boundless Bio (Nasdaq: BOLD), a clinical-stage oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to patients with previously intractable oncogene ...

Goldman Sachs challenges the view that 5% yields on U.S. Treasuries are a breaking point for stocks, citing no consistent ...

A concoction of factors — war, inflation, lower earnings — has led to lackluster performance for equities so far this year.

Goldman Sachs has moderated its risk-taking since U.S. President Donald Trump's April tariff announcement, and the Wall ...

European stocks traded higher on Thursday ahead of an expected interest-rate cut by the European Central Bank. Investors have fully priced in a 25 basis-point cut, bringing the deposit rate to 2%, and ...

Investors, consumers and policymakers may justifiably fear the specter of tariff-fueled inflation later this year and beyond, ...

Meet 14 execs who helped lead private equity's secondaries market to a record $160 billion in deals last year.

Deutsche Bank has raised its year-end target for the S&P 500 to 6,550 from 6,150, citing lower tariff-related earnings drag ...

China has grappled with entrenched deflationary pressure, as a prolonged real estate downturn and job insecurity hamper ...

Sentiment toward carry trades has been re-energized in recent weeks as global trade tensions have eased. A gauge of global ...

RBC on Monday raised its year-end target for the S&P 500 index to 5,730 from 5,550, reflecting a modestly improved U.S.